Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its ...

The restaurant group announced Tuesday that Jose Alberto Dueñas is stepping down. Chief financial officer Paul Carbone, a ...

(Reuters) -Oilfield services provider Flowco Holdings on Tuesday said it is seeking a valuation of up to $2 billion in its ...

Spanish travel technology firm HBX Group is considering announcing plans for an initial public offering as early as next week ...

Ahead of opening its share sale, the company raised over Rs 130 crore from anchor investors on Monday, January 6, 2025.

Bloks Group Ltd., the popular maker of Ultraman and Transformers figurines, raised HK$1.67 billion ($215 million) in Hong ...

On the first-day share sale process, the IPO was fully subscribed within minutes and closed with a 13.32 times subscription.

The IPO opened for subscription on Tuesday and has already been subscribed 13.81 times as of the end of Day 1. By Wednesday ...

Just a month after announcing a $115 million series D financing to advance its lead assets, Maze Therapeutics is looking to ...

BR Goyal IPO opened for subscription on January 7 and closes on January 9. The ₹85 crore SME IPO is fully subscribed, with a ...

Drug developer Maze Therapeutics Inc.'s rollercoaster ride is leading to the Bay Area's first biotech IPO filing of 2025.

The main difference between going public through an initial public offering (IPO) and staying private lies in ownership ...